Sierra Oncology Inc

NASDAQ:SRRA  
54.75
+0.02 (+0.04%)
Other Pre-Announcement

Sierra Oncology Reports First Quarter 2022 Results

Published: 05/06/2022 11:13 GMT
Sierra Oncology Inc (SRRA) - Sierra Oncology Reports First Quarter 2022 Results.
Qtrly Net Loss per Common Share, Basic and Diluted $1.33.
Q1 Earnings per Share View $-1.03 -- Refinitiv Ibes Data (analyst estimates).